The present paper describes the development of a reversed-phase high performance liquid chromatographic (RP-HPLC) method for N-Bromosuccinimide (NBS) determination in group of “sartans” pharmaceuticals. The gradient LC method employs solution A and solution B as mobile phase. The solution A contains 0.01%v/v Ortho-phosphoric buffer and Acetonitrile as Solution B. Successful chromatographic separation were achieved on a Zorbax XDB C18, 250mm x 4.6mm, 5μm particle size column without co-elution of drugs and its process related impurities and degradation products. The developed RP-HPLC method was validated with respect to specificity, linearity, accuracy, precision and sensitivity with detection limits and quantification limits are 0.007 mg/ml and 0.022 mg/ml respectively [1]. To the best of our knowledge, a rapid LC method for the determination of NBS in pharmaceuticals, disclosed in this investigation was not published elsewhere.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report